Umme Habiba Ferdaushi has completed her MBBS at Shere Bangla Medical College, Barisal, Bangladesh and fellowship in Cardiology at Bangladesh College of Physicians and Surgeons (BCPS), Bangladesh. She works at National Institute of Cardiovascular Diseases (NICVD), a tertiary level cardiovascular institute. She has published three papers in reputed journals.
Abstract
Cardiac Resynchronization Therapy (CRT) is the established management for HF patients with LV systolic dysfunction and signs of electrical dyssynchrony. Some patients after CRT implantation become ‘super-responders’. Our proposed definition of super-responders is patients with an increase LVEF of ≥15% and an improvement of (NYHA) functional class (at least 1 class). The aim of our study was to identify predictors of being a super-responder to CRT in our population.
Thirty five consecutive patients underwent CRT for a period of one year were studied prospectively. Before and 3months after implantation clinical, electrocardiographic and echocardiographic evaluations were performed. At the 3 months follow-up, patients were classified as ‘super-responders’.
Of the 35patients, there were17.1%super-responders. At baseline, there were some signiï¬cant differences between super-responders and the other patients that they had signiï¬cantly smaller LV end-diastolic diameter (65.4±6.4vs.73.4±9.3mm,P=0.001), smaller degree of MR(mean 1.9±0.9vs.2.6+0.8,P=<0.001), smaller left atrium (42.8±4.6vs.50.0±6.5 mm, P < 0.001), a shorter duration of HF symptoms (months; 15.1±17.8vs.33.9±35.7,P=0.01) and they all had non-ischemic cardiomyopathy. After 3 months, we observed a significant improvement of NYHA functional class, LVEF, LV diameters, MR grade in both groups. Regarding the magnitude of response LV diameters, LVEF showed a significantly greater improvement in super-responders. In the multivariate logistic regression analysis, MR grade, LVEDD and the duration of symptoms for <12 months were independent predictors of super-response to CRT.